Anderson M.E. . .. Update on survival in osteosarcoma.” Orthopedic Clinics of North America, 47(2016) : 283-292.
Luetke A. . .Osteosarcoma treatment - where do we stand? a state of the art review. ” Cancer Treatment Reviews, 40(2014) : 523-532.
Hawkins D.S.,Arndt C.A. .2003 .Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy. ” Cancer, 98(11) : 2447-2456.
Mirabello L. . .Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance. Epidemiology and End Results Program.” Cancer, 115(2009) : 1531-1543.
Gill J.,Gorlick R. .2021 .Advancing therapy for osteosarcoma. ” Nature Reviews Clinical Oncology, 18(10) : 609-624.
Regan D.P. . .Losartan blocks osteosarcoma-elicited monocyte recruitment and combined with the kinase inhibitor toceranib, exerts significant clinical benefit in canine metastatic osteosarcoma. ” Clinical Cancer Research, 28(2022) : 662-676.
Morrow J.J,Khanna C. .2015 .Osteosarcoma genetics and epigenetics: emerging biology and candidate therapies. ” Critical Reviews in Oncogenesis, 20(3-4) : 173-197.
Benjamin R.S. .2020 .Adjuvant and neoadjuvant chemotherapy for osteosarcoma: a historical perspective. ” Advances in Experimental Medicine and Biology, 1257 : 1-10.
Hattinger C.M. . .Advances in emerging drugs for osteosarcoma. ” Expert Opinion on Emerging Drugs, 20(2015) : 495-514.
Thorn C.F. . .Doxorubicin pathways: pharmacodynamics and adverse effects. ” Pharmacogenetics and Genomics, 21(2011) : 440-446.
Lourda M. . .Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of clusterin/apolipoprotein. International Journal of Cancer, 120(2007) : 611-622.
Suwei D. .2015 .NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. ” Journal of Hematology & Oncology, 120 : .
Rotondo R. .2022 .The sesquiterpene lactone cynaropicrin manifests strong cytotoxicity in glioblastoma cells U-87 MG by induction of oxidative stress. ” Biomedicines, 10(7) : .
Lage H. “ .2008 .An overview of cancer multidrug resistance: a still unsolved problem. ” Cellular and Molecular Life Sciences, 65(20) : 3145-3167.
Housman G. . .Drug resistance in cancer: an overview. ” Cancers, 6(2014) : 1769-1792.
Sharom F.J. “ . .The P-glycoprotein multidrug transporter. , 50(2011) : 161-178.